Risk-Based Monitoring and Trial Optimization

Risk-Based Monitoring (RBM) has become a standard approach to improve trial efficiency and data quality while focusing oversight on critical risks. This session delves into the design and implementation of RBM strategies using centralized, remote, and on-site monitoring techniques. Attendees will learn how to identify key risk indicators, develop monitoring plans, and leverage technology platforms for real-time tracking. Emphasis is placed on cross-functional collaboration between data managers, monitors, and safety teams. Case studies will illustrate how RBM reduces monitoring burden, enhances protocol compliance, and supports adaptive trial designs. Regulatory perspectives on RBM adoption and documentation requirements will also be addressed.

    Related Conference of Risk-Based Monitoring and Trial Optimization

    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Risk-Based Monitoring and Trial Optimization Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in